1. Identification of an imidazopyridine scaffold to generate potent and selective TYK2 inhibitors that demonstrate activity in an in vivo psoriasis model. Issue 18 (15th September 2017) Authors: Liang, Jun; Van Abbema, Anne; Balazs, Mercedesz; Barrett, Kathy; Berezhkovsky, Leo; Blair, Wade S.; Chang, Christine; Delarosa, Donnie; DeVoss, Jason; Driscoll, Jim; Eigenbrot, Charles; Goodacre, Simon; Ghilardi, Nico; MacLeod, Calum; Johnson, Adam; Bir Kohli, Pawan; Lai, Yingjie; Lin, Zhonghua; ... Journal: Bioorganic & medicinal chemistry letters Issue: Volume 27:Issue 18(2017) Page Start: 4370 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Structural basis of the broadly neutralizing anti‐interferon‐α antibody rontalizumab. (18th August 2015) Authors: Maurer, Brigitte; Bosanac, Ivan; Shia, Steven; Kwong, Mandy; Corpuz, Racquel; Vandlen, Richard; Schmidt, Kerstin; Eigenbrot, Charles Journal: Protein science Issue: Volume 24:Number 9(2015:Sep.) Page Start: 1440 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗